Wassil J, Sisti M, Fairman J, Rankin B, et al. A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older. Vaccine 2024 Jul 17:S0264-410X(24)00786-2. doi: 10.1016/j.vaccine.2024.
PMID: 39025698